Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Shift Towards a 'Comprehensive Care Continuum' with the Adoption of Integrated Care Pathways that Combine Clinical Therapies with Wellness Programs
* Required Fields
Pay by invoice
This is a premium access report. To purchase click on the buy now button. Use code: FROSTCMHC60 to access our promotional pricingGlobally, cardiometabolic diseases are witnessing a consistent rise in prevalence every year, with hypertension and diabetes among the leading conditions. A rising population of hypertension is, in turn, leading to growing incidence of chronic heart failure with about 26 million cases of CHF globally. Although drug therapies are the first line of treatment in cases of CHF, hypertension, and diabetes, obesity treatment requires a mixture of nutritional, behavioral, and drug therapies, wherein drugs act as an adjunct to the behavioral therapies. With the growing number of cardiometabolic cases worldwide, the market is slowly shifting toward ‘Therapy-as-a-Service’ model, with the implementation of adjunct therapies such as digital therapeutics, AI-based predictive diagnostic tools as well as nutritional and behavioral therapies alongside traditional drug treatment. This has helped establish a comprehensive care continuum across the industry, with wellness programs playing an important role in disease diagnosis, treatment, and monitoring.
The present study aims at identifying some of the key growth opportunities, which are set to drive the market in the next few years. Additionally, the study also identifies the most prevalent and emerging business models across the market, which are supporting industry stakeholders in enhancing their geographic coverage in terms of patient outreach and address challenges of inadequate patient access. The study provides in-depth revenue and market analysis of 4 key markets, chronic heart failure (CHF), hypertension, diabetes, and obesity. The study also highlights some of the key market drivers and restraints that affect the growth. It gives an overview of the competitive environment providing brief insights on some of the game-changing participants across each segment that are working toward developing disruptive technologies and drugs, thus maintaining their growth trajectory. Focus is also given on some of the leading M&A activities impacting the market as well as present and future market trends that would shape the market.
Key Issues Addressed
Fill in the fields below to receive a sample report
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.